Saving sight: using AI to diagnose diabetic eye disease

SKIP TO CONTENT
Search
Logo
RMIT Australia
Students
Alumni & Giving
Staff
Library
RMIT Online

Saving sight: using AI to diagnose diabetic eye disease

Researchers have used artificial intelligence to support the instant diagnosis of one of the top causes of blindness, diabetes-related eye disease, in its earliest stages.

Diabetic retinopathy is the leading cause of vision loss in adults and its impact is growing worldwide, with 191 million people set to be affected by 2030.

There are no early-stage symptoms and the disease may already be advanced by the time people start losing their sight. Early diagnosis and treatment can make a dramatic difference to how much vision a patient retains.

Now a team of Australian-Brazilian researchers led by RMIT University have developed an image-processing algorithm that can automatically detect one of the key signs of the disease, fluid on the retina, with an accuracy rate of 98%.

Lead investigator Professor Dinesh Kant Kumar, RMIT, said the method was instantaneous and cost-effective.

“We know only half of those with diabetes have regular eye exams and one-third have never been checked,” Kumar said. 

“But the gold standard methods of diagnosing diabetic retinopathy are invasive or expensive, and often unavailable in remote or developing parts of the world.

“Our AI-driven approach delivers results that are just as accurate as clinical scans but relies on retinal images that can be generated with ordinary optometry equipment.

“Making it quicker and cheaper to detect this incurable disease could be life changing for the millions of people who are currently undiagnosed and risk losing their sight.”

Fluorescein angiography and optical coherence tomography scans are currently the most accurate clinical methods for diagnosing diabetic retinopathy.

An alternative and cheaper method is analysing images of the retina that can be taken with relatively inexpensive equipment called fundus cameras, but the process is manual, time-consuming and less reliable.

08 January 2019

Share

A fundus image of a retina, with damaged areas highlighted by the image-processing algorithm. A fundus image of a retina, with damaged areas highlighted by the image-processing algorithm.

To automate the analysis of fundus images, researchers in the Biosignals Laboratory in the School of Engineering at RMIT, together with collaborators in Brazil, used deep learning and artificial intelligence techniques.

The algorithm they developed can accurately and reliably spot the presence of fluid from damaged blood vessels, or exudate, inside the retina.

The researchers hope their method could eventually be used for widespread screening of at-risk populations.

“Undiagnosed diabetes is a massive health problem here and around the globe,” Kumar said.

“For every single person in Australia who knows they have diabetes, another is living with diabetes but isn’t diagnosed. In developing countries, the ratio is one diagnosed to four undiagnosed.

“This results in millions of people developing preventable and treatable complications from diabetes-related diseases.

“With further development, our technology has the potential to reduce that burden.”

The researchers are in discussions with manufacturers of fundus cameras about potential collaborations to advance the technology.

The research - with lead author Parham Khojasteh and collaborators from Federal University of Sao Carlos, Federal Institute of Sao Paolo, University of Campinas and Sao Paolo State University - is published in Computers in Biology and Medicine (January 2019, Volume 104, DOI:10.1016/j.compbiomed.2018.10.031).

Be part of the conversation about Empowering Health! Join local and international leaders from industry, research and innovation, 18-20 February at RMIT. Find out more at Engaging for Impact 2019.

Story: Gosia Kaszubska

08 January 2019

Share

  • Research
  • Science and technology
Engage

Related News

A lifeline for premature born babies: Funding announced for new stem cell research

RMIT is part a group of researchers from across the globe developing a new therapy that aims to see if stem cells can be used to regenerate the brain damage caused by premature birth. This brain damage is called ‘encephalopathy of prematurity’ (EOP).

Bacteria shredding tech to fight drug-resistant superbugs

Researchers have used liquid metals to develop new bacteria-destroying technology that could be the answer to the deadly problem of antibiotic resistance.

Game changer: New software for stroke rehab

A new touch-screen therapy tool could accelerate the recovery of patients who have suffered a stroke and change the way rehabilitation is delivered in hospitals and homes.

What’s next for the future of nutrition?

Forget kombucha and think bugs – an RMIT expert says we need to look towards nutrients and foods that are both kinder to us, and to the planet.

Show more
Subscribe to RMIT NewsSubscribe
Flag Image One Flag Image Two

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business.

More information
Study with Us
Life at RMIT
Research
For business
About